Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Depreciation & Amortization (CF) (2022 - 2025)

Historic Depreciation & Amortization (CF) for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to $76000.0.

  • Envoy Medical's Depreciation & Amortization (CF) rose 5510.2% to $76000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $297000.0, marking a year-over-year increase of 7167.63%. This contributed to the annual value of $200000.0 for FY2024, which is 5037.59% up from last year.
  • As of Q3 2025, Envoy Medical's Depreciation & Amortization (CF) stood at $76000.0, which was up 5510.2% from $85000.0 recorded in Q2 2025.
  • Envoy Medical's Depreciation & Amortization (CF)'s 5-year high stood at $85000.0 during Q2 2025, with a 5-year trough of $26000.0 in Q4 2022.
  • For the 4-year period, Envoy Medical's Depreciation & Amortization (CF) averaged around $48416.7, with its median value being $45000.0 (2023).
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first soared by 2592.59% in 2024, then surged by 10238.1% in 2025.
  • Quarter analysis of 4 years shows Envoy Medical's Depreciation & Amortization (CF) stood at $26000.0 in 2022, then soared by 84.62% to $48000.0 in 2023, then soared by 56.25% to $75000.0 in 2024, then increased by 1.33% to $76000.0 in 2025.
  • Its Depreciation & Amortization (CF) stands at $76000.0 for Q3 2025, versus $85000.0 for Q2 2025 and $61000.0 for Q1 2025.